Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07009210 · ClinicalTrials.gov registry record · NA
AI Assisted Personalized Legacy Program (Reflections: My Story) for Patients With Serious Illness
A NA study of Serious Illness and Existential Distress, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT07009210 is a NA study of Serious Illness and Existential Distress that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 40 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT07009210, a NA study of Serious Illness and Existential Distress, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the AI Assisted Personalized Legacy Program intervention to patients with serious illness.
Conditions Studied
Interventions
- BEHAVIORAL AI Assisted Personalized Legacy Program
Study Locations (2)
Arizona
- Mayo Clinic - Phoenix
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-08-11 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07009210
The ClinicalTrials.gov registry entry for NCT07009210 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Serious Illness appearing as the primary indexed condition, and to 1 intervention - of which AI Assisted Personalized Legacy Program is the first listed.
NCT07009210 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Minnesota.
Frequently Asked Questions
What is clinical trial NCT07009210 about?
NCT07009210 is a clinical study titled "AI Assisted Personalized Legacy Program (Reflections: My Story) for Patients With Serious Illness". The purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the AI Assisted Personalized Legacy Program intervention to patients with serious illness.
What is the current status of trial NCT07009210?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-08-11. Estimated completion is 2027-06.
What conditions does trial NCT07009210 study?
This clinical trial studies the following conditions: Serious Illness, Existential Distress.
What interventions are being tested in trial NCT07009210?
The interventions under investigation include: AI Assisted Personalized Legacy Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT07009210?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07009210 being conducted?
This trial has 2 study locations across Arizona, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Serious Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.